Literature DB >> 4453608

The leishmaniases.

E A Steck.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4453608     DOI： 10.1007/978-3-0348-7087-0_22

Source DB:  PubMed          Journal:  Prog Drug Res        ISSN： 0071-786X


× No keyword cloud information.
  6 in total

1.  Characterization of the antimonial antileishmanial agent meglumine antimonate (glucantime).

Authors:  W L Roberts; W J McMurray; P M Rainey
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

2.  Use of in vitro method to assess different brands of anti-leishmanial drugs.

Authors:  S K Arora; R Sinha; S Sehgal
Journal:  Med Microbiol Immunol       Date:  1991       Impact factor: 3.402

3.  Protective effect of glucan against visceral leishmaniasis in hamsters.

Authors:  J A Cook; T W Holbrook; W J Dougherty
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

4.  Antileishmanial activity of sodium stibogluconate fractions.

Authors:  W L Roberts; P M Rainey
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

5.  In vitro antileishmanial properties of tri- and pentavalent antimonial preparations.

Authors:  W L Roberts; J D Berman; P M Rainey
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

Review 6.  Pentavalent antimonials: new perspectives for old drugs.

Authors:  Frédéric Frézard; Cynthia Demicheli; Raul R Ribeiro
Journal:  Molecules       Date:  2009-06-30       Impact factor: 4.411
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.